These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7071819)

  • 1. Cerebro spinal fluid C2 and HLA system in multiple sclerosis.
    Delasnerie-Laupretre N; Suet-Hubert C; Marcelli-Barge A
    Tissue Antigens; 1982 Jan; 19(1):79-84. PubMed ID: 7071819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis in north-east Scotland. An association with HLA-DQw1.
    Francis DA; Batchelor JR; McDonald WI; Hing SN; Dodi IA; Fielder AH; Hern JE; Downie AW
    Brain; 1987 Feb; 110 ( Pt 1)():181-96. PubMed ID: 3492235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden.
    Hägglöf B; Holmgren G; Holmlund G; Lindblom B; Olaisen B; Teisberg P
    Hum Hered; 1986; 36(4):201-12. PubMed ID: 3639057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of properdin factor B in Japanese. Description of a rare variant and data of association with HLA and C2.
    Tokunaga K; Araki C; Juji T; Omoto K
    Hum Genet; 1982; 60(1):42-5. PubMed ID: 6918356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis: immunogenetic analyses of sib-pair double case families. II. Studies on the association of multiple sclerosis with C2, C4, BF, C3, C6, and GLO polymorphisms.
    Schröder R; Zander H; Andreas A; Mauff G
    Immunobiology; 1983 Mar; 164(2):160-70. PubMed ID: 6552216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and cerebrospinal fluid C2 in multiple sclerosis.
    Delasnerie-Laupretre N; Prevot D; Martin-Mondiere C; Eizenbaum JF; Degos JD; Sobel AT
    J Clin Lab Immunol; 1981 Jul; 6(1):23-5. PubMed ID: 7265172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypocomplementaemic multiple sclerosis: heterozygous C2 deficiency linked to HLA A10, B18.
    Trouillas P; Berthoux F; Betuel H; Boisson D; Aimard G; Devic M
    Lancet; 1976 Nov; 2(7993):1023. PubMed ID: 62239
    [No Abstract]   [Full Text] [Related]  

  • 8. Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, and III antigens in 111 Japanese narcoleptics.
    Matsuki K; Juji T; Tokunaga K; Naohara T; Satake M; Honda Y
    J Clin Invest; 1985 Dec; 76(6):2078-83. PubMed ID: 3865934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular heterogeneity of second and fourth components of complement and their genes in systemic sclerosis and association of HLA alleles A1, B8 and DR3 with limited and DR5 with diffuse systemic sclerosis.
    Venneker GT; van den Hoogen FH; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; Boerbooms AM; de Waal LP; Bos JD; Asghar SS
    Exp Clin Immunogenet; 1998; 15(2):90-9. PubMed ID: 9691203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA and multiple sclerosis: population and families study.
    Govaerts A; Gony J; Martin-Mondiére C; Poirier JC; Schmid M; Schuller E; Degos JD; Dausset J
    Tissue Antigens; 1985 Apr; 25(4):187-99. PubMed ID: 3874450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human MHC class III (Bf, C2, C4) genes and GLO: their association with other HLA antigens and extended haplotypes in the Spanish population.
    Regueiro JR; Arnaiz-Villena A
    Tissue Antigens; 1988 Jan; 31(1):14-25. PubMed ID: 3341017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of alleles of the second complement component (C2) on Canadian HLA haplotypes.
    Marshall WH; Barnard JM; Churchill D; Farid NR; Grandy R; Larsen B; Payne RH; Skanes VM; Ebers GC; Paty DW
    Tissue Antigens; 1984 Apr; 23(4):229-39. PubMed ID: 6729809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [11th International Histocompatibility Workshop 1991: Personal data for the Multiple Sclerosis Study].
    Wegener S; Falk U; Lakner K; Meyer-Riennecker HJ; Hauptmann G; Uring-Lambert B
    Beitr Infusionsther; 1992; 30():324-31. PubMed ID: 1284726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended major histocompatibility complex haplotypes in patients with multiple sclerosis.
    Hauser SL; Fleischnick E; Weiner HL; Marcus D; Awdeh Z; Yunis EJ; Alper CA
    Neurology; 1989 Feb; 39(2 Pt 1):275-7. PubMed ID: 2783768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complement markers Bf and C4 in multiple sclerosis].
    Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B
    Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HLA system and multiple sclerosis.
    Jersild C
    Birth Defects Orig Artic Ser; 1978; 14(5):123-70. PubMed ID: 99191
    [No Abstract]   [Full Text] [Related]  

  • 17. HLA antigens in multiple sclerosis of northern Spanish population.
    López-Larrea C; Uría DF; Coto E
    J Neurol Neurosurg Psychiatry; 1990 May; 53(5):434-5. PubMed ID: 2351974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency in Spanish population of familial complement factor 2 type I deficits and associated HLA haplotypes.
    Antolín SC; Del Rey Cerros MJ; Sierra EM; Miñarro DO; Clemente J; Martínez LA; Peña PV; Panete MJ; Pérez PM; Paz-Artal E
    Hum Immunol; 2005 Oct; 66(10):1093-8. PubMed ID: 16386652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland.
    Haegert DG; Swift FV; Benedikz J
    Neurology; 1996 Apr; 46(4):1107-11. PubMed ID: 8780100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of a C2 DNA polymorphism in RA, Felty's and normal subjects.
    Clarkson R; Sanders PA; Grennan DM
    Exp Clin Immunogenet; 1990; 7(1):64-8. PubMed ID: 1971759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.